IL-1βR-dependent priming of antitumor CD4<sup>+</sup> T cells and sustained antitumor immunity after peri-tumoral treatment with MSU and mycobacteria.

Oncoimmunology · 2015 · PMC4589042 · PMID 26451307

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

extremely significantno p-value reported

Differences of p < 0.05 were deemed significant (*), p < 0.01 very significant (**) and p < 0.001 extremely significant (***).

also in 7,787 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.